Przejdź do zawartości
Merck

Effects of tetramethylpyrazine on neuronal apoptosis in the superficial dorsal horn in a rat model of neuropathic pain.

The American journal of Chinese medicine (2012-12-12)
Yu-Fang Leng, Xiang-Mei Gao, Shu-Xiu Wang, Yan-Hong Xing
ABSTRAKT

The Bennett and Xie (1988) model of chronic constriction injury (CCI) investigated the effects of tetramethylpyrazine (TMP) on neuropathic pain-associated behaviors and neuronal apoptosis in the spinal dorsal horn. Fifty-four male rats were randomly divided into sham (group S), CCI (group C) and TMP groups (group T). Each group was divided into subgroups (n = 6 in each group) according the time of sacrifice: 3 d, 7 d and 14 d. Rat sciatic nerves were unligated (group S), or the right sciatic nerve was loosely ligated (groups C and T) to produce CCI. Mechanical withdrawal thresholds (MWTs) and thermal withdrawal latencies (TWLs) were measured, and the rats were sacrificed at different time points post-operation. The L4-L6 sections of the spinal cord were removed. Apoptotic changes were evaluated using the TUNEL method. Immunohistochemistry assessed Bcl-2 and caspase-3 expression. TMP treatment increased MWT and TWL values and Bcl-2 expression, but it reduced neuronal apoptosis and caspase-3 expression in laminae I-II of the spinal dorsal horn. These results suggested that the inhibition of neuronal apoptosis via the modulation of Bcl-2 and caspase-3 proteins in the rat spinal dorsal horn contributed to TMP-induced analgesia.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Supelco
2,3,5,6-Tetramethylpyrazine, analytical standard
Sigma-Aldrich
2,3,5,6-Tetramethylpyrazine, ≥98%, FG
Sigma-Aldrich
2,3,5,6-Tetramethylpyrazine, natural, ≥98%, FG
Sigma-Aldrich
2,3,5,6-Tetramethylpyrazine, 98%